CVX vs DHR: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Chevron Corporation · Energy
$175.91
-3.4% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
CVX trades at a lower forward P/E
(30.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
DHR |
| Current Price |
$175.91 |
$195.98 |
| Fair Value Estimate |
$169.96 |
$211.54 |
| Upside to Fair Value |
-3.4%
|
+7.9%
|
| Market Cap |
$350.3B |
$138.7B |
| Forward P/E |
30.4x
|
37.8x
|
| EV / EBITDA |
9.4x
|
22.8x
|
| Price / Sales |
1.9x
|
5.6x
|
| Price / FCF |
26.2x
|
26.2x
|
| Revenue Growth YoY |
+3.2%
|
+3.7%
|
| Gross Margin |
25.4%
|
60.7%
|
| Operating Margin |
8.4%
|
21.0%
|
| Return on Equity |
6.2%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.82%
|
3.81%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company within the energy sector, demonstrating medium business quality with a stable competitive position but facing earnings pressure as evidenced by a 36.9% decline in earnings in the most recent quarter. The stock trades at a premium valuation with a P/E trailing and forward of 30.38, EV/EBITDA of 9.41, and a P/FCF of 26.2, refl…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
CVX |
DHR |
| Zone Low |
$127.47 |
$158.66 |
| Zone High |
$144.47 |
$179.81 |
| In Buy Zone? |
No
|
No
|